Summary of Bill HR 1776
Bill 118 hr 1776, also known as the End Tuberculosis Now Act of 2023, is a piece of legislation introduced in the US Congress with the goal of addressing the ongoing issue of tuberculosis (TB) in the United States. The bill aims to improve prevention, diagnosis, and treatment of TB in order to ultimately eliminate the disease.
Key provisions of the bill include increasing funding for TB research and development of new treatments, as well as expanding access to TB testing and treatment for at-risk populations. The bill also calls for increased coordination between federal, state, and local health agencies to better track and respond to TB outbreaks.
Additionally, the End Tuberculosis Now Act of 2023 seeks to raise awareness about TB and reduce stigma associated with the disease. This includes promoting education and outreach programs to inform the public about the importance of early detection and treatment of TB.
Overall, the bill aims to strengthen the nation's efforts to combat TB and work towards the goal of eradicating the disease. It emphasizes the importance of collaboration between government agencies, healthcare providers, and community organizations in order to effectively address the TB epidemic in the United States.
Congressional Summary of HR 1776
End Tuberculosis Now Act of 2023
This bill authorizes actions, including the provision of international assistance, to combat tuberculosis.
The President may provide international assistance to prevent, treat, control, and eliminate tuberculosis. The President must also establish goals for U.S. efforts to detect, cure, and prevent all forms of tuberculosis globally by updating the National Action Plan for Combating Multidrug-Resistant Tuberculosis.
The Government Accountability Office must periodically report to Congress on the impact of efforts to combat tuberculosis that are supported by U.S. bilateral assistance.